Myosin IXb variants and their pivotal role in maintaining the intestinal barrier: A study in Crohn’s disease

References

• Buhner S, Buning C, Genschel J, Kling K, Herrmann D, Dignass A, et al. Genetic basis for increased intestinal permeability in families with Crohn’s disease: role of CARD15 3020insC mutation? Gut 2006;55:342–7.
   PubMed Web of Science ®Google Scholar
• Prager M, Buttner J, Haas V, Baumgart DC, Sturm A, Zeitz M, et al. The JAK2 variant rs10758669 in Crohn’s disease: altering the intestinal barrier as one mechanism of action. Int J Colorectal Dis 2012;27:565–73.
   PubMedGoogle Scholar
• De Gottardi A, McCoy KD. Evaluation of the gut barrier to intestinal bacteria in non-alcoholic fatty liver disease. J Hepatol 2011;55:1181–3.
   PubMed Web of Science ®Google Scholar
• Vaarala O. Leaking gut in type 1 diabetes. Curr Opin Gastroenterol 2008;24:701–6.
   PubMed Web of Science ®Google Scholar
• Soderholm JD, Olaison G, Lindberg E, Hannestad U, Vindels A, Tysk C, et al. Different intestinal permeability patterns in relatives and spouses of patients with Crohn’s disease: an inherited defect in mucosal defence? Gut 1999;44:96–100.
   PubMed Web of Science ®Google Scholar
• John LJ, Fromm M, Schulzke JD. Epithelial barriers in intestinal inflammation. Antioxid redox signal 2011;15:1255–70.
   PubMed Web of Science ®Google Scholar
• Bruewer M, Hopkins AM, Hobert ME, Nusrat A, Madara JL. RhoA, Rac1, and Cdc42 exert distinct effects on epithelial barrier via selective structural and biochemical modulation of junctional proteins and F-actin. Am J Physiol Cell Physiol 2004;287:C327–35.
   PubMed Web of Science ®Google Scholar
• Matter K, Balda MS. Signalling to and from tight junctions. Nat rev Mol Cell Biol 2003;4:225–36.
   PubMed Web of Science ®Google Scholar
• Muller RT, Honnert U, Reinhard J, Bahler M. The rat myosin myr 5 is a GTPase-activating protein for Rho in vivo: essential role of arginine 1695. Mol biol cell 1997;8:2039–53.
   PubMed Web of Science ®Google Scholar
• Post PL, Tyska MJ, O’Connell CB, Johung K, Hayward A, Mooseker MS. Myosin-IXb is a single-headed and processive motor. J biol chem 2002;11679–83.
   PubMedGoogle Scholar
• Wirth JA, Jensen KA, Post PL, Bement WM, Mooseker MS. Human myosin-IXb, an unconventional myosin with a chimerin-like rho/rac GTPase-activating protein domain in its tail. J Cell Sci 1996;109:653–61.
   PubMed Web of Science ®Google Scholar
• Monsuur AJ, de Bakker PI, Alizadeh BZ, Zhernakova A, Bevova MR, Strengman E, et al. Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect. Nat Genet 2005;37:1341–4.
   PubMed Web of Science ®Google Scholar
• Irvine EJ, Marshall JK. Increased intestinal permeability precedes the onset of Crohn’s disease in a subject with familial risk. Gastroenterology 2000;119:1740–4.
   PubMed Web of Science ®Google Scholar
• van Bodegraven AA, Curley CR, Hunt KA, Monsuur AJ, Linskens RK, Onnie CM, et al. Genetic variation in myosin IXB is associated with ulcerative colitis. Gastroenterology 2006;131:1768–74.
   PubMed Web of Science ®Google Scholar
• Dignass A, Eliakim R, Magro F, Maaser C, Chowers Y, Geboes K, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. J Crohns colitis 2012;6:965–90.
   PubMed Web of Science ®Google Scholar
• Van Assche G, Dignass A, Panes J, Beaugerie L, Karagiannis J, Allez M, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn’s disease: Definitions and diagnosis. J Crohns colitis 2010;4:7–27.
   PubMed Web of Science ®Google Scholar
• Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005;19:Suppl A):5A–36A.
   PubMed Web of Science ®Google Scholar
• Buhner S, Reese I, Kuehl F, Lochs H, Zuberbier T. Pseudoallergic reactions in chronic urticaria are associated with altered gastroduodenal permeability. Allergy 2004;59:1118–23.
   PubMed Web of Science ®Google Scholar
• Wyatt J, Vogelsang H, Hubl W, Waldhoer T, Lochs H. Intestinal permeability and the prediction of relapse in Crohn’s disease. Lancet 1993;341:1437–9.
   PubMed Web of Science ®Google Scholar
• Post PL, Bokoch GM, Mooseker MS. Human myosin-IXb is a mechanochemically active motor and a GAP for rho. J Cell sci 1998;111:941–50.
   PubMedGoogle Scholar
• Menke V, Van Zoest KP, Moons LM, Pot RG, Siersema PD, Kuipers EJ, et al. Myo9B is associated with an increased risk of Barrett’s esophagus and esophageal adenocarcinoma. Scand J Gastroenterol 2012;47:1422–8.
   PubMed Web of Science ®Google Scholar
• Chandhoke SK, Mooseker MS. A role for myosin IXb, a motor-RhoGAP chimera, in epithelial wound healing and tight junction regulation. Mol biol cell 2012;23:2468–80.
   Google Scholar
• Hanley PJ, Xu Y, Kronlage M, Grobe K, Schon P, Song J, et al. Motorized RhoGAP myosin IXb (Myo9b) controls cell shape and motility. Proc Natl Acad Sci USA 2010;107:12145–50.
   PubMed Web of Science ®Google Scholar
• Nunez C, Oliver J, Mendoza JL, Gomez-Garcia M, Pinero A, Taxonera C, et al. MYO9B polymorphisms in patients with inflammatory bowel disease. Gut 2007;56:1321–2.
   PubMed Web of Science ®Google Scholar
• Wolters VM, Xu W, Zhao X, Walters TD, Griffiths AM, Silverberg MS, et al. Replication of genetic variation in the MYO9B gene in Crohn’s disease. Hum immunol 2011;72:592–7.
   PubMedGoogle Scholar
• Cooney R, Cummings JR, Pathan S, Beckly J, Geremia A, Hancock L, et al. Association between genetic variants in myosin IXB and Crohn’s disease. Inflamm Bowel Dis 2009;15:1014–21.
   PubMed Web of Science ®Google Scholar
• Latiano A, Palmieri O, Valvano MR, D’Inca R, Caprilli R, Cucchiara S, et al. The association of MYO9B gene in Italian patients with inflammatory bowel diseases. Aliment pharmacol ther 2008;27:241–8.
   PubMed Web of Science ®Google Scholar